Cancer Progress is going Virtual for its 31st annual conference

In light of the ongoing and still evolving novel coronavirus (COVID-19) outbreak, and with the most recent announcement by the CDC ( on the latest restrictions on gatherings over 50 people, the Cello Health Cancer Progress Committee has made the difficult decision to convert this event to a two-day series of webinars on the original dates in place of the face-to-face event.

Therefore, Cancer Progress will be held virtually May 5th-6th. Please keep these dates available on your calendars.
As we make our final plans to run this virtually, we will continue to update our website and send additional information as soon as it becomes available.

Stay safe and look forward to meeting virtually!

Keynote Speaker

Michael A. Curran, PhD

Michael A. Curran, PhD
Associate Professor, Dept. of Immunology Scientific Director
ORBIT Platform,The University of Texas MD Anderson Cancer Center
Department of Immunology, Division of Basic Sciences

Thank You to our 2020 Sponsors and Supporters


Convene at 32 Old Slip
32 Old Slip, New York, NY 10005 | 1.888.730.7307


“I truly enjoyed the conference. I told several colleagues and friends that this has been one of the best conferences I have ever attended.”

Christoph Lengauer, Chief Scientific Officer

Blueprint Medicines

“What an unbelievable 2-day event that was. The intimate atmosphere (I made great new contacts) and dynamic (sometimes “dynamic tension”) interaction between panel members was fantastic. I kept great notes and have already shared the very enthusiastic feedback & takeaways with my management team.”

Armand Girard, Vice President, Corporate Development


“Thank you for the opportunity. I felt privileged to be part of a panel composed of stellar leaders within the Oncology space.”

Noemi Rosa


“I really enjoyed the meeting as usual – great topics and speakers. I look forward to next year’s meeting!”

Richard Brian Gaynor, Sr. Vice President Global Development / Medical Affairs, Oncology Business Unit

Eli Lilly and Company